PLI's Uneven Record Exposes the Component Gap Beneath Assembly

Mobile-manufacturing PLI has drawn 312% of its targeted investment, but Electronic Components sits at 68% and Bulk Drugs at 48% — evidence that incentivising finished products localises assembly while the dependency migrates one layer down, into the components.